A24 IPF: CLINICAL STUDIES, THERAPEUTICS, AND MORE I: Baseline Characteristics Of The Initial 200 Participants In The Pulmonary Fibrosis Foundation Registry

Introduction/Rationale: Detailed understanding of patient demographics and longitudinal assessments (including response to therapy and applicable biomarkers) for interstitial lung diseases (ILD) in usual care, real-world settings are lacking. Information from baseline medical history, physical exami...

Full description

Saved in:
Bibliographic Details
Published in:American journal of respiratory and critical care medicine 2017-01, Vol.195
Main Authors: Flaherty, K R, de Andrade, J A, Chou, W, Lancaster, L H, Lindell, K O, Nathan, S D, Raghu, G, Spino, C, Stauffer, J L, Tuomey, P, Wolters, P J, Cosgrove, G P
Format: Article
Language:English
Subjects:
Biopsy
Enrollments
Family medical history
Pulmonary fibrosis
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Introduction/Rationale: Detailed understanding of patient demographics and longitudinal assessments (including response to therapy and applicable biomarkers) for interstitial lung diseases (ILD) in usual care, real-world settings are lacking. Information from baseline medical history, physical examination, pulmonary function testing, and chest CT images obtained as part of usual care are collected.
ISSN:1073-449X
1535-4970